XenoPort gets Japanese rec for RLS med; Sri Lanka plots price controls;

 @FiercePharma: Sanofi abandons authorized Lovenox generic, now that Amphastar's copy isn't a threat to brand sales--Bloomberg. More | Follow @FiercePharma

> XenoPort won a recommendation from Japanese regulators for its restless legs syndrome treatment, to be marketed under the name Regnite; the drug is sold in the U.S. by GlaxoSmithKline ($GSK) as Horizant. Article

> The Sri Lankan government is planning a new price-control program on drugs to begin next month. News

> Mylan ($MYL) won final FDA approval for its version of the Pfizer ($PFE) injectable for hemophilia patients, Cyklokapron. Item

> Hungary's Gedeon Richter nabbed exclusive distribution and marketing rights for the uterine treatment Esmya in Russia, China and several other markets. Story

> Britain's FDS Pharma bought SciGen Israel's Rehovot plant for $2 million plus 5 royalties on the hepatitis vaccine made there. Report

> China's Guangdong Taiantang Pharmaceutical plans to buy Chaozhou Shanyuan Investment for 136 million yuan, giving it an indirect 52.4% stake in Guangzhou Hongxing Group, a well-known Chinese brand that makes patented drugs. More

Biotech News

 @FierceBiotech: Novartis aiming to impress investors, academics as it presents flurry of data on its growing cancer franchise. Article | Follow@FierceBiotech

 @RyanMFierce: Profile on former Icahn biotech lieutenant Alex Denner via Bloomberg--Still not many details on his hedge fund. Item | Follow @RyanMFierce

 @JohnCFierce: U.K. offering $280M catalyst fund, patient data access for biotech R&D. Story | Follow @JohnCFierce

 @MarkHFierce: The Aussies have found a gene that stops skin cancer. Treatments could follow in 5 years? We'll see. More | Follow @MarkHFierce

> Affymax investors bullish on FDA review of Amgen anemia drug rival. News

> Can Denner's new hedge fund replicate Icahn's golden biotech touch? Article

Medical Device News

> Integra opens Shanghai office. News

> Qualcomm unit to provide wireless solutions for devices. More

> Moog taps Scannell as CEO. Item

IT News

> Microsoft co-founder Allen urges open science to speed breakthroughs. Story

> Startup Spiral Genetics takes shot at bioinformatics. Article

> AstraZeneca taps IT outsourcing firm Cognizant. News

And Finally... A salary dispute with doctors at Slovakian hospitals has been resolved, saving the country's medical system from breakdown. News

Suggested Articles

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.

Gilead is hoping to score a patent extension on TAF meds, but patient advocates say that would reward conduct that harmed patients.